Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Molecular Immunology|November 1, 1988
Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell linesS Brunati, C Miossec, C Mathiot, et al.International Reviews of Immunology|January 1, 1997
Fc receptors as targets for immunotherapyH Rouard, S Tamasdan, J Moncuit, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiationJ L Teillaud, N Gruel, J Moncuit, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Isolation and partial characterization of messenger RNA, from murine T cell hybrids, coding for suppressive immunoglobulin G-binding factorC Vaqero, W H Fridman, J Moncuit, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 29, 1998
Chemical imaging of nucleic acids, proteins and lipids of a single living cell. Application of synchrotron infrared microspectrometry in cell biologyN Jamin, P Dumas, J Moncuit, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometryN Jamin, P Dumas, J Moncuit, et al.Journal of Immunological Methods|November 5, 1993
Detection and quantification of secreted soluble Fc gamma RIIA in human sera by an enzyme-linked immunosorbent assayA Astier, H de la Salle, J Moncuit, et al.Immunomethods|February 1, 1994
Natural and recombinant soluble low-affinity Fc gamma R: detection, purification, and functional activitiesJ L Teillaud, C Bouchard, A Astier, et al.Hybridoma|February 10, 1998
A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assaysF Vely, N Gruel, J Moncuit, et al.Leukemia & Lymphoma|July 1, 1997
Soluble Fcgamma receptor, Fc gammaRIIa2, is present in two forms in human serum and is increased in patients: with stage C chronic lymphocytic leukemiaA Astier, H Merle-Beral, H de la Salle, et al.Pageof 3